The pharmacists fighting high drug prices

Snakebite kills tens of thousands of people every year, many of them in rural communities where treatment can be delayed, expensive or difficult to reach. In southern Nepal, reporter Craig Langran joins a community organiser responding to snake rescue calls and teaching villagers ...  Show more

Sexual and gender-based violence remains a reality for many women. In this programme we go to Rwanda to meet survivors who are beginning to find their voice after years of silence. We follow projects led by the development charity Tearfund and meet Sabine Nkusi, the organisation' ...  Show more

On this week's episode of Networth and Chill, I'm joined by author and CEO of Rhoshan Pharmaceuticals, Hitha Palepu to talk drug prices and the pharmaceutical industry. Drug prices are a hot topic these days, and it seems like the cost of life saving medications like insulin and ...  Show more

It's hard to put a value on a human life. When you're well, perhaps you don't think about it. But if you're ill, getting access to the right drugs, whatever the cost, is a priority. But the NHS does not have a bottomless pit of money. And some medicines are judged too expensive t ...  Show more

A year ago, Congress overhauled the way drugs for older Americans get paid for, by giving Medicare the power to bargain with drug makers over prices in the biggest change to health care for more than a decade. This week, the Biden administration began its implementation.

Gilead Sciences announced today that it will charge the U.S. government and other developed countries $390 per vial for its coronavirus-fighting drug remdesivir. That begins to answer a big question as drug companies race to find treatments and develop vaccines for the virus: How ...  Show more